Introduction

Bioinformatics and molecular diagnostic technologies (tests that analyse the DNA or RNA to detect a disease) have improved the diagnosis process, with a higher precision, speed, and coverage, compared to old diagnostic procedures. These integrated techniques enable doctors to detect and define illnesses at the molecular level, allowing for earlier intervention, more accurate diagnosis, and individualised treatment plans. Combining new molecular tools and extensive computer analysis has altered diagnostic capacities for infectious illnesses, genetic disorders, cancer, and other ailments.¹ 

This article focuses on bioinformatics and molecular diagnostic technologies, their use in various illnesses, and the upcoming trends that may impact the future of diagnosis in clinical microbiology, epidemiology, and personalised medicine.

Molecular diagnostic technologies

The foundation of molecular diagnostic techniques in clinical laboratories comprises nucleic acid amplification technologies, specifically polymerase chain reaction (PCR) and its variations. These methods have completely changed the diagnosis of infectious diseases by making it possible to quickly and accurately identify pathogens directly from clinical samples (blood tests, urine analysis, etc).¹ 

PCR-based methods

Polymerase Chain Reaction (PCR) techniques, particularly real-time PCR (also known as quantitative PCR - qPCR), have become the cornerstone of molecular diagnostics in various diseases, including emergency settings. These methods allow for rapid and sensitive detection of pathogenic organisms (viruses, bacteria, parasites), significantly reducing the time to diagnosis compared to traditional culture-based methods.² 

Real-time PCR can identify many pathogenic organisms that cause infectious-disease emergencies (Haemophilus influenzae B, Neisseria meningitidis, Mycoplasma pneumoniae, Clostridium difficile, etc) in both, immunocompetent (presenting normal immunity), and immunocompromised patients.²

Next-Generation Sequencing (NGS)

NGS, supported by bioinformatics and phylogenetic analyses, has proven invaluable in pathogen identification and characterisation. This technology enables whole genome sequencing (WGS) of infectious agents, providing comprehensive genetic information for accurate identification and strain typing.³ NGS has been successfully used to identify clinically relevant viruses and bacteria such as Francisella tularensis (causing tularemia) and Leptospira variety (causing leptospirosis) from primary human clinical specimens.³

High-Resolution Melting (HRM) analysis

HRM is a novel molecular diagnostic technique based on qPCR, that detects certain pathogens faster, with higher resolution and lower contamination risk. Based on the principle that different double-stranded DNA molecules have different melting temperatures, HRM uses fluorescent dyes or probes to monitor changes in the melting curve.⁴ This technique is beneficial for species identification, genotyping, and the detection of certain genes that cause drug resistance.⁴

Bioinformatics applications

Bioinformatics is the computational framework that converts raw molecular data into useful diagnostic information. In infectious diseases, dedicated bioinformatics tools have been created to evaluate sequencing data for pathogen identification and characterisation. The open-source bioinformatics tool called ‘DAMIAN’ (Detection & Analysis of viral and Microbial Infectious Agents by NGS), for example, is designed exclusively for identifying pathogens in diagnostic samples. This program detects infectious agents quickly and reliably, and it can precisely categorise viral diseases down to the strain level, making it especially useful for epidemic investigations.^5,6

Pathogen identification and characterisation

Bioinformatics tools are crucial in analysing the vast amounts of data generated by molecular diagnostic techniques. These tools are extensively used in identifying, characterising, and typing all kinds of pathogens.³ They enable the detection of virulence factors, resistome analysis, and more, providing a comprehensive understanding of the pathogen's genetic makeup and potential clinical implications.³

Multi-omics data analysis

Combining multi-omics data with machine learning (ML) and artificial intelligence techniques allows for detailed profiling of various biological processes. This approach facilitates disease diagnosis, prognosis, and personalised medicine strategies.⁵ By analysing patient-specific omics datasets, researchers can develop personalised medicine techniques and improve vaccine development by identifying novel antigens and immune responses.⁵

Surveillance and outbreak prediction

Using bioinformatics tools and molecular diagnostic data enables scientists to increase various disease surveillance and predict possible outbreaks. These technologies offer the opportunity of early detection and real-time monitoring of a pandemic, allowing for more effective public health interventions.⁵

Advantages and future perspectives

The integration of bioinformatics and molecular diagnostic technologies offer several advantages over traditional diagnostic methods:

• Increased sensitivity and specificity: Molecular methods can detect pathogens at much lower levels than traditional culture-based techniques, with higher specificity (when a negative test is true-negative)⁴
• Rapid diagnosis: Many molecular diagnostic tests provide results in hours rather than days, enabling faster clinical decision-making²
• Comprehensive pathogen profiling: These technologies allow for the simultaneous detection of multiple pathogens and the characterisation of their genetic traits, including virulence factors and antibiotic resistance genes^3,4
• Personalised medicine: By analysing individual genetic profiles, these technologies support tailored treatment approaches and optimise the management of the disease⁵

Future directions

Portable and low-cost devices

The development of portable molecular diagnostic devices (for example a portable device to detect COVID-19) will enable rapid testing in resource-limited settings and rural-remote areas, critical for early outbreak detection and a more effective disease control.⁷

Artificial Intelligence (AI) integration

AI and machine learning algorithms will continue to enhance data analysis, improving diagnostic accuracy and predictive capabilities.⁵

Expanded applications

Molecular diagnostics will play an increasing role in personalised medicine, vaccine development, and understanding pathogen evolution.⁵

Summary

The synergy between bioinformatics and molecular diagnostic technologies has transformed the process of diagnosing a disease, offering powerful tools for rapid, accurate, and comprehensive pathogen identification and characterisation. As these technologies evolve, they hold promise of revolutionising clinical practice, epidemiological analysis, and public health management, especially in infectious diseases.